Investor News
Indivior Announces Ruling by the Court of Appeals for the Federal Circuit in ANDA Litigation
Read moreIndivior Statement Regarding Reckitt Benckiser Settlement
Read moreIndivior Raises FY 2019 Net Revenue and Net Income Guidance; Cash at H1 2019 Expected to be Approximately $985m
Read moreH1 2019 Results Presentation on July 31 at 11:30 a.m. BST / 6:30 a.m. EDT
Webcast link
Read moreIndivior Announces Validation of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA) for SUBOXONE® (buprenorphine and naloxone) Sublingual Film
Read moreNew Data from the RECOVER™ Study Reports on Abstinence, Drug Craving and Psychosocial Outcomes in People with Opioid Use Disorder following Transition from a Clinical Trial to the Real-World Setting
Read moreJefferies 2019 Global Healthcare Conference Presentation
Read moreIndivior to present at Jeffries 2019 Healthcare Conference
Read moreJefferies 2019 Global Healthcare Conference
June 4th at 10:30 a.m. (New York City Time)
Read more